{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:38:20Z","timestamp":1792712300795,"version":"4.5.0"},"update-to":[{"DOI":"10.1016\/j.lfs.2025.123819","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023MH144"],"award-info":[{"award-number":["ZR2023MH144"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.lfs.2025.123819","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T18:18:29Z","timestamp":1750529909000},"page":"123819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["RETRACTED: Dapagliflozin attenuates diabetic cardiomyopathy via NRF2 protein upregulation-driven glutathione synthesis to inhibit myocardial ferroptosis"],"prefix":"10.1016","volume":"378","author":[{"given":"Xuepin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2025.123819_bb0005","doi-asserted-by":"crossref","unstructured":"Williams R, Karuranga S, Malanda B, et al. Global and regional estimates and projections of diabetes-related health expenditure: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res. Clin. Pract. 2020;162:108072.","DOI":"10.1016\/j.diabres.2020.108072"},{"issue":"9","key":"10.1016\/j.lfs.2025.123819_bb0010","first-page":"1893","article-title":"Diabetic myocardial disorder. A clinical consensus statement of the heart failure association of the ESC and the ESC working group on Myocardial & Pericardial Diseases","volume":"26","author":"Seferovi\u0107","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.lfs.2025.123819_bb0015","doi-asserted-by":"crossref","first-page":"1140644","DOI":"10.3389\/fendo.2023.1140644","article-title":"Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Endocrinol (Lausanne)"},{"key":"10.1016\/j.lfs.2025.123819_bb0020","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41401-023-01068-9","article-title":"Wang, Y, regulated cell death pathways in cardiomyopathy","volume":"44","author":"Sheng","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2025.123819_bb0025","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","article-title":"Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2025.123819_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106086","article-title":"CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis","volume":"176","author":"Chen","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2025.123819_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108330","article-title":"Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease","volume":"242","author":"Solomon","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"10254","key":"10.1016\/j.lfs.2025.123819_bb0040","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.lfs.2025.123819_bb0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.lfs.2025.123819_bb0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.1432","article-title":"A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)","volume":"21","author":"McMurray","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"10.1016\/j.lfs.2025.123819_bb0055","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00210-022-02243-1","article-title":"Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction","volume":"395","author":"Ma","year":"2022","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2025.123819_bb0060","doi-asserted-by":"crossref","first-page":"1078205","DOI":"10.3389\/fphar.2023.1078205","article-title":"Dapagliflozin alleviates myocardial ischemia\/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123819_bb0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12933-018-0790-0","article-title":"SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats","volume":"17","author":"Durak","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123819_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-021-01312-8","article-title":"Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGF\u03b21\/Smad signaling","volume":"20","author":"Zhang","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123819_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12964-020-00663-1","article-title":"The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma","volume":"18","author":"Tang","year":"2020","journal-title":"Cell Commun. Signal"},{"issue":"4","key":"10.1016\/j.lfs.2025.123819_bb0080","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated Ferroptosis","volume":"127","author":"Fang","year":"2020","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.lfs.2025.123819_bb0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-5223(19)37950-4","article-title":"Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man","volume":"79","author":"Flameng","year":"1980","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.lfs.2025.123819_bb0090","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.lfs.2025.123819_bb0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated Ferroptosis","volume":"127","author":"Fang","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2025.123819_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102201","article-title":"Ferroptosis: mechanisms and role in diabetes mellitus and its complications","volume":"94","author":"Liu","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.lfs.2025.123819_bb0105","doi-asserted-by":"crossref","first-page":"2071952","DOI":"10.1155\/2017\/2071952","article-title":"Hawthorn leaf flavonoids protect against diabetes-induced cardiomyopathy in rats via PKC-\u03b1 signaling pathway","volume":"2017","author":"Min","year":"2017","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"7","key":"10.1016\/j.lfs.2025.123819_bb0110","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.lfs.2025.123819_bb0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.freeradbiomed.2008.10.040","article-title":"Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress","volume":"46","author":"Harvey","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2025.123819_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2025.123819_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2025.123819_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.123819_bb0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41420-022-01218-8","article-title":"Role of ferroptosis on tumor progression and immunotherapy","volume":"8","author":"Gong","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.lfs.2025.123819_bb0140","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41420-023-01713-6","article-title":"A novel microtubule inhibitor promotes tumor ferroptosis by attenuating SLC7A11\/GPX4 signaling","volume":"9","author":"Ning","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123819_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116991","article-title":"Dapagliflozin dampens liver fibrosis induced by common bile duct ligation in rats associated with the augmentation of the hepatic Sirt1\/AMPK\/PGC1\u03b1\/FoxO1 axis","volume":"489","author":"Hassan","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123819_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10557-018-6778-x","article-title":"Combined SGLT2 and DPP4 inhibition reduces the activation of the Nlrp3\/ASC Inflammasome and attenuates the development of diabetic nephropathy in mice with type 2 diabetes","volume":"32","author":"Birnbaum","year":"2018","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"2","key":"10.1016\/j.lfs.2025.123819_bb0155","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/ehf2.15150","article-title":"Dapagliflozin alleviates high-fat-induced obesity cardiomyopathy by inhibiting ferroptosis","volume":"12","author":"Chen","year":"2025","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.lfs.2025.123819_bb0160","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.2147\/OTT.S254995","article-title":"The role of Erastin in Ferroptosis and its prospects in Cancer therapy","volume":"13","author":"Zhao","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.lfs.2025.123819_bb0165","doi-asserted-by":"crossref","first-page":"9999612","DOI":"10.1155\/2021\/9999612","article-title":"Mechanism of Ferroptosis and its role in type 2 diabetes mellitus","volume":"2021","author":"Sha","year":"2021","journal-title":"J. Diabetes Res."},{"issue":"17","key":"10.1016\/j.lfs.2025.123819_bb0170","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/cells11172726","article-title":"Molecular mechanisms of Ferroptosis and relevance to cardiovascular disease","volume":"11","author":"Xie","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.lfs.2025.123819_bb0175","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1039\/C1DT11205H","article-title":"A new approach to the ferritin iron core growth: influence of the H\/L ratio on the core shape","volume":"41","author":"L\u00f3pez-Castro","year":"2012","journal-title":"Dalton Trans."},{"issue":"11","key":"10.1016\/j.lfs.2025.123819_bb0180","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1089\/ars.2013.5666","article-title":"Coupling heme and iron metabolism via ferritin H chain","volume":"20","author":"Gozzelino","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2025.123819_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101470","article-title":"Ferroptosis and ferritinophagy in diabetes complications","volume":"60","author":"He","year":"2022","journal-title":"Mol Metab."}],"updated-by":[{"DOI":"10.1016\/j.lfs.2025.123819","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}},{"DOI":"10.1016\/j.lfs.2026.124335","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000}},{"DOI":"10.1016\/j.lfs.2026.124335","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000}}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525004540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525004540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:33:07Z","timestamp":1775187187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525004540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":37,"alternative-id":["S0024320525004540"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123819","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Dapagliflozin attenuates diabetic cardiomyopathy via NRF2 protein upregulation-driven glutathione synthesis to inhibit myocardial ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123819"}}